PLXNA3 and neoplasm: This phenomenon may be attributed to sex hormone (particularly estrogen)-mediated activation of oncogenic pathways, X chromosome-driven establishment of a gender-specific tumor microenvironment, and differences in healthcare-seeking behaviors between sexes (18–20).